Cobalt chloride-stimulated hypoxia promotes the proliferation of cholesteatoma keratinocytes via the PI3K/Akt signaling pathway

被引:9
|
作者
Zhang, Chen [1 ]
Chen, Min [1 ,2 ]
Tao, Qi [3 ]
Chi, Zhangcai [1 ,2 ]
机构
[1] Fudan Univ, Eye & ENT Hosp, Dept Otolaryngol, 83 Fenyang Rd, Shanghai, Peoples R China
[2] Fudan Univ, NHC Key Lab Hearing Med, Shanghai 200031, Peoples R China
[3] Fudan Univ, Eye & ENT Hosp, Dept Nursing, 83 Fenyang Rd, Shanghai, Peoples R China
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2021年 / 18卷 / 15期
关键词
hypoxia; cholesteatoma; HIF-1; alpha; cell proliferation; PI3K/Akt signaling pathway; CELL-PROLIFERATION; MIDDLE-EAR; EXPRESSION; PROTEIN;
D O I
10.7150/ijms.60617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herein, we purposed to explore whether hypoxia triggers proliferation of cholesteatoma keratinocytes via the PI3K-Akt signaling cascade. Cells were inoculated with different concentration of CoCl2. The proliferation and cellular HIF-1 alpha, p-PDK1 and p-Akt expression levels of cholesteatoma keratinocytes were assessed in vitro. Hypoxia escalated cell proliferation via upregulating p-PDK1 and p-Akt expressions. Specific inhibitor of the PI3K-Akt signaling cascade, LY294002 markedly inhibited the expression of p-Akt and significantly reduces the hypoxia-induced proliferation of cholesteatoma keratinocytes. Our data provides research evidence confirming that hypoxia participates in the onset and progress of cholesteatoma.
引用
收藏
页码:3403 / 3411
页数:9
相关论文
共 50 条
  • [41] Berberine promotes the viability of random skin flaps via the PI3K/Akt/eNOS signaling pathway
    Chen, Jianpeng
    Jiang, Zhikai
    Liu, Xuao
    Wang, Kaitao
    Fan, Weijian
    Chen, Tingxiang
    Li, Zhijie
    Lin, Dingsheng
    PHYTOTHERAPY RESEARCH, 2023, 37 (02) : 424 - 437
  • [42] Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
    Lin, Lin
    Gao, Yunan
    Hu, Xiaochen
    Ouyang, Jiabao
    Liu, Chunbo
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [43] NICASTRIN REGULATES CELL PROLIFERATION AND APOPTOSIS OF HEPATOCELLULAR CARCINOMA VIA PI3K/AKT SIGNALING PATHWAY
    Wang, Xicheng
    Li, Wenxin
    Yan, Maolin
    Wang, Xining
    Xu, Yunxiuxiu
    Chen, Tao
    Chen, Jie
    HEPATOLOGY, 2019, 70 : 1198A - 1198A
  • [44] Daphnoretin inhibits glioblastoma cell proliferation and metastasis via PI3K/AKT signaling pathway inactivation
    Lei, Jiaming
    Zhou, Hong
    Cheng, Shijiao
    Yu, Wenwen
    Yang, Meiting
    Lin, Li
    JOURNAL OF CANCER, 2024, 15 (17): : 5810 - 5827
  • [45] Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway
    Zhu, Xinbing
    Li, Rongnian
    Wang, Chen
    Zhou, Shuo
    Fan, Yujia
    Ma, Shuang
    Gao, Didi
    Gai, Nian
    Yang, Jing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Tetrahydropalmatine promotes random skin flap survival in rats via the PI3K/AKT signaling pathway
    Yang, Jialong
    Deng, Jiapeng
    Wang, Kaitao
    Wang, An
    Chen, Guodong
    Chen, Qingyu
    Ye, Minle
    Wu, Xinyu
    Wang, Xinye
    Lin, Dingsheng
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 324
  • [47] Glutinol inhibits the proliferation of human ovarian cancer cells via PI3K/AKT signaling pathway
    Chen, Yuanyuan
    Lie, Juan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (07) : 1331 - 1335
  • [48] Apatinib suppresses the proliferation and apoptosis of gastric cancer cells via the PI3K/Akt signaling pathway
    Jia, Xiaoqiong
    Wen, Zhenping
    Sun, Qiuying
    Zhao, Xiaohua
    Yang, Hao
    Shi, Xiaoyu
    Xin, Tao
    JOURNAL OF BUON, 2019, 24 (05): : 1985 - 1991
  • [49] Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
    Lin Lin
    Yunan Gao
    Xiaochen Hu
    Jiabao Ouyang
    Chunbo Liu
    BMC Women's Health, 22
  • [50] Polyphyllin II inhibits breast cancer cell proliferation via the PI3K/Akt signaling pathway
    Miao, Weiwei
    Wang, Zhixiong
    Gao, Jianwen
    Ohno, Yuko
    MOLECULAR MEDICINE REPORTS, 2024, 30 (06)